Acta Scientific Biotechnology

Short Communication Volume 2 Issue 1

Xeroderma Pigmentosum

Dhvani H Kuntawala*

Department of Life Sciences, De Montfort University, United Kingdom

*Corresponding Author: Dhvani H Kuntawala, Department of Life Sciences, De Montfort University, United Kingdom.

Received: December 05, 2020; Published: December , 2020


  Xeroderma pigmentosum, which is known as XP, is a rare inherited disease characterized the maximum sensitivity of the sun and ultraviolet rays, resulting in pigment changes, sunburn and increased rates of mucus membrane cancers. It is an autosomal recessive disorder with the possibility of starting a 10,000-fold growth in skin cancer in patients having XP below the age of 20 years. It was in the late 19th century when dermatologist Moritz Kaposi led the road to understanding XP. During 1874, Kaposi used the term “xeroderma” to describe four patients with this disease. Dr. Albert Neisser reported the first XP case with neurological indications and later in the second decade, DeSanctis and Cacchione outlined XP with acute neurological deficiency known as “DeSanctis-Cacchione syndrome” [1].



Citation: Dhvani H Kuntawala. “Xeroderma Pigmentosum". Acta Scientific Biotechnology 2.1 (2021): .


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

Contact US